Members directory | Become a member | My DCVMN

Contact us

DCVMN Advocacy

June 2, 2024

DCVMN at the “Advancing Biomanufacturing Workforce Training for Global Health Equity” Advocacy Event

CEO DCVMN Advocacy Workforce Training

June 2, 2024

DCVMN CEO Attended a Private Session at the Permanent Mission of France to the UN in Geneva

CEO DCVMN Advocacy Sustainable Regional Manufacturing WeConnectToProtect

May 29, 2024

DCVMN Joint Statement at WHA77

DCVMN Advocacy Pandemic Preparedness Statement Vaccines & immunization

May 24, 2024

DCVMN Teamed Up with Leading Vaccine Experts and Manufacturers to Co-author an Article on the Pandemic Agreement

Article CEO DCVMN Advocacy DCVMNpartnerships Pandemic Preparedness

April 11, 2024

DCVMN Board at the World Vaccine Congress

DCVMN Advocacy DCVMN Board developingcountries Vaccines & immunization

April 10, 2024

DCVMN at the World Vaccine Congress Biodefence Pre-Workshop

CEO DCVMN Advocacy Pandemic Preparedness Vaccines & immunization

April 3, 2024

DCVMN CEO Engagements in Addis Ababa

Africa CEO DCVMN Advocacy developingcountries WeConnectToProtect

March 31, 2024

DCVMN CEO at the International Conference on Innovation, Intellectual Property, and Technology Transfer in Africa’s Pharmaceutical Sector

CEO Conference DCVMN Advocacy

March 18, 2024

DCVMN Chairing “Facilitating Technology Transfer to Promote Local Manufacturing and Access to Vaccines, Medicines, and Health Technologies in Sub-Saharan Africa” Conference

CEO Conference DCVMN Advocacy

March 14, 2024

DCVMN Joint Statement with IFPMA and Trade Associations on Biopharmaceutical Industry Commitments

DCVMN Advocacy developingcountries Statement WeConnectToProtect

Our sponsors

Our sponsors

Our sponsors

Our sponsors